“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More” Ok, I agree

Nivolumab (Opdivo)

Trade Name : OPDIVO

E.R. Squibb & Sons, L.L.C.

INJECTION

Strength 10 mg/mL

NIVOLUMAB Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Nivolumab (Opdivo) which is also known as OPDIVO and Manufactured by E.R. Squibb & Sons, L.L.C.. It is available in strength of 10 mg/mL per ml. Read more

Nivolumab (Opdivo) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Indications and Usage u00a0u00a0u00a0u00a0u00a0u00a03/2020Dosage and Administration u00a0u00a0u00a0u00a0u00a0u00a03/2020Warnings and Precautions u00a0u00a0u00a0u00a0u00a0u00a03/2020Warnings and Precautions u00a0u00a0u00a0u00a0u00a0u00a09/2019
  • OPDIVO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of:
  • a
  • Arrayn- Array
  • Arrayn- Array
  • No data
  • Arrayn- Array
  • Arrayn- Array
  • Arrayn- Array
  • Arrayn- Array
  • Arrayn- Array
  • Arrayn- Array
  • Arrayn- Array
  • Arrayn- Array
  • Arrayn- Array
  • Arrayn- Array
  • Injection: 40 mg/4 mL (10 mg/mL), 100 mg/10 mL (10 mg/mL), and 240 mg/24 mL (10 mg/mL) clear to opalescent, colorless to pale-yellow solution in a single-dose vial.
  • Injection: 40 mg/4 mL, 100 mg/10 mL, and 240 mg/24 mL solution in a single-dose vial. n
  • None.
  • u2022
  • (4)
  • No data
  • Immune-mediated pneumonitis
  • Immune-mediated colitis
  • Immune-mediated hepatitis
  • Immune-mediated endocrinopathies
  • Immune-mediated nephritis and renal dysfunction
  • Immune-mediated skin adverse reactions
  • Immune-mediated encephalitis
  • Infusion-related reactions
  • Complications of allogeneic HSCT
  • Embryo-Fetal toxicity
  • The following clinically significant adverse reactions are described elsewhere in the labeling.
  • Most common adverse reactions (incidence u226520%) in patients were:
  • To report SUSPECTED ADVERSE REACTIONS, contact Bristol-Myers Squibb at 1-800-721-5072 or FDA at 1-800-FDA-1088 or .
  • Lactation: Advise not to breastfeed. n
  • Nivolumab is a programmed death receptor-1 (PD-1) blocking antibody. Nivolumab is an IgG4 kappa immunoglobulin that has a calculated molecular mass of 146 kDa. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line.
  • OPDIVO is a sterile, preservative-free, non-pyrogenic, clear to opalescent, colorless to pale-yellow liquid that may contain light (few) particles.
  • OPDIVO (nivolumab) injection for intravenous use is supplied in single-dose vials. Each mL of OPDIVO solution contains nivolumab 10 mg, mannitol (30 mg), pentetic acid (0.008 mg), polysorbate 80 (0.2 mg), sodium chloride (2.92 mg), sodium citrate dihydrate (5.88 mg), and Water for Injection, USP. May contain hydrochloric acid and/or sodium hydroxide to adjust pH to 6.
  • No data
  • No data
  • No data
  • OPDIVO (nivolumab) Injection is available as follows:
  • Store under refrigeration at 2u00b0C to 8u00b0C (36u00b0F to 46u00b0F). Protect from light by storing in the original package until time of use. Do not freeze or shake.
  • Advise the patient to read the FDA-approved patient labeling .
  • Immune-Mediated Adverse Reactions
  • Inform patients of the risk of immune-mediated adverse reactions that may require corticosteroid treatment and withholding or discontinuation of OPDIVO, including:
  • Infusion-Related Reactions
  • Complications of Allogeneic HSCT
  • Embryo-Fetal Toxicity
  • Lactation
  • Manufactured by:Bristol-Myers Squibb CompanyPrinceton, NJ 08543 USAU.S. License No. 1713
  • OPDIVO (op-DEE-voh)n- (nivolumab)n- Injection
  • This Medication Guide has been approved by the U.S. Food and Drug Administration.
  • Revised: March 2020
  • See section for a complete list of available packages of OPDIVO.
  • NDC 0003-3772-11Rx only
  • Opdivon (nivolumab)injection
  • 40 mg/4 mL(10 mg/mL)
  • For intravenous Infusion OnlySingle-dose vial; Discard unused portion.Please provide enclosed Medication Guide to the patient.
  • Bristol-Myers Squibb
  • NDC 0003-3774-12Rx only
  • Opdivon (nivolumab)injection
  • 100 mg/10 mL(10 mg/mL)
  • For Intravenous Infusion OnlySingle-dose vial; Discard unused portion.Please provide enclosed Medication Guide to the patient.
  • Bristol-Myers Squibb
  • NDC 0003-3734-13Rx only
  • Opdivon (nivolumab)injection
  • 240 mg/24 mL(10 mg/mL)
  • For Intravenous Infusion OnlySingle-dose vial; Discard unused portion.Please provide enclosed Medication Guide to the patient.
  • Bristol-Myers Squibbn

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Desogestrel And Ethinyl Estradiol (Emoquette)

Manufacturer: REMEDYREPACK INC.

Presentation: KIT

Strength:

Pack Size:

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET

Strength: 2.5; .025 mg/1; mg/1

Pack Size:

Fluoxetine Hydrochloride (Fluoxetine)

Fluoxetine Hydrochloride (Fluoxetine)

Manufacturer: REMEDYREPACK INC.

Presentation: CAPSULE

Strength: 40 mg/1

Pack Size:

Metoprolol Succinate (Metoprolol Succinate)

Metoprolol Succinate (Metoprolol Succinate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, EXTENDED RELEASE

Strength: 25 mg/1

Pack Size:

Losartan Potassium (Losartan Potassium)

Losartan Potassium (Losartan Potassium)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, FILM COATED

Strength: 25 mg/1

Pack Size:

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Get Price

Are you an existing customer or a vendor of GNH India? Log in here to

View your Transaction
COMPANY
SERVICES
QUICK LINKS
CONTACT US
Registered Office Address:

Unit # G- 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi,
Mumbai 400025 India

US Office Address:

GNH Pharmaceuticals USA LLC,
Suite E # 499, 1235 EAST BLVD,
Charlotte, NC, 28203, U.S.A
TEL: +1 704 557 0412

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.